APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hirudin

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Selected research

Market Structure

Global Hirudin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17328735031 January 2026184 pages

Choose your research edition.

Industry ResearchHirudin Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Hirudin Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Hirudin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hirudin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hirudin Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

The report provides an overview of the global Hirudin market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Hirudin and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hirudin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hirudin market size, projected growth trends, production technologies, key applications, and end-use industries.

Hirudin Segment by Company

The Medicines Company

Keyken

Minapharm

Abbott

SALUBRIS

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

DUOPUTAI

Pentapharm

Hirudin Segment by Type

Natural Hirudin

Recombinant Hirudin

Hirudin Segment by Application

Thrombosis Disease

Tumor Disease

Others

Hirudin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hirudin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hirudin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hirudin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hirudin market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hirudin industry.

Chapter 3: Detailed analysis of Hirudin market competition landscape. Including Hirudin manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Hirudin by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Hirudin Industry Trends Table 2. Hirudin Industry Drivers Table 3. Hirudin Industry Opportunities and Challenges Table 4. Hirudin Industry Restraints Table 5. Global Hirudin Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hirudin Production Value Share by Manufacturers (2021-2026) Table 7. Global Hirudin Production by Manufacturers (MT) & (2021-2026) Table 8. Global Hirudin Production Market Share by Manufacturers Table 9. Global Hirudin Average Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Hirudin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hirudin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hirudin Manufacturers, Product Type & Application Table 13. Global Hirudin Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hirudin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Natural Hirudin Table 17. Major Manufacturers of Recombinant Hirudin Table 18. Global Hirudin Production by Type 2021 VS 2025 VS 2032 (MT) Table 19. Global Hirudin Production by Type (2021-2026) & (MT) Table 20. Global Hirudin Production by Type (2027-2032) & (MT) Table 21. Global Hirudin Production Market Share by Type (2021-2026) Table 22. Global Hirudin Production Market Share by Type (2027-2032) Table 23. Global Hirudin Production Value by Type 2021 VS 2025 VS 2032 (MT) Table 24. Global Hirudin Production Value by Type (2021-2026) & (MT) Table 25. Global Hirudin Production Value by Type (2027-2032) & (MT) Table 26. Global Hirudin Production Value Market Share by Type (2021-2026) Table 27. Global Hirudin Production Value Market Share by Type (2027-2032) Table 28. Major Manufacturers of Thrombosis Disease Table 29. Major Manufacturers of Tumor Disease Table 30. Major Manufacturers of Others Table 31. Global Hirudin Production by Application 2021 VS 2025 VS 2032 (MT) Table 32. Global Hirudin Production by Application (2021-2026) & (MT) Table 33. Global Hirudin Production by Application (2027-2032) & (MT) Table 34. Global Hirudin Production Market Share by Application (2021-2026) Table 35. Global Hirudin Production Market Share by Application (2027-2032) Table 36. Global Hirudin Production Value by Application 2021 VS 2025 VS 2032 (MT) Table 37. Global Hirudin Production Value by Application (2021-2026) & (MT) Table 38. Global Hirudin Production Value by Application (2027-2032) & (MT) Table 39. Global Hirudin Production Value Market Share by Application (2021-2026) Table 40. Global Hirudin Production Value Market Share by Application (2027-2032) Table 41. The Medicines Company Company Information Table 42. The Medicines Company Business Overview Table 43. The Medicines Company Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 44. The Medicines Company Hirudin Product Portfolio Table 45. The Medicines Company Recent Development Table 46. Keyken Company Information Table 47. Keyken Business Overview Table 48. Keyken Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 49. Keyken Hirudin Product Portfolio Table 50. Keyken Recent Development Table 51. Minapharm Company Information Table 52. Minapharm Business Overview Table 53. Minapharm Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 54. Minapharm Hirudin Product Portfolio Table 55. Minapharm Recent Development Table 56. Abbott Company Information Table 57. Abbott Business Overview Table 58. Abbott Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 59. Abbott Hirudin Product Portfolio Table 60. Abbott Recent Development Table 61. SALUBRIS Company Information Table 62. SALUBRIS Business Overview Table 63. SALUBRIS Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 64. SALUBRIS Hirudin Product Portfolio Table 65. SALUBRIS Recent Development Table 66. Pfizer, Inc Company Information Table 67. Pfizer, Inc Business Overview Table 68. Pfizer, Inc Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 69. Pfizer, Inc Hirudin Product Portfolio Table 70. Pfizer, Inc Recent Development Table 71. Teva Pharmaceutical Industries Ltd Company Information Table 72. Teva Pharmaceutical Industries Ltd Business Overview Table 73. Teva Pharmaceutical Industries Ltd Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Industries Ltd Hirudin Product Portfolio Table 75. Teva Pharmaceutical Industries Ltd Recent Development Table 76. DUOPUTAI Company Information Table 77. DUOPUTAI Business Overview Table 78. DUOPUTAI Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. DUOPUTAI Hirudin Product Portfolio Table 80. DUOPUTAI Recent Development Table 81. Pentapharm Company Information Table 82. Pentapharm Business Overview Table 83. Pentapharm Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Pentapharm Hirudin Product Portfolio Table 85. Pentapharm Recent Development Table 86. Global Hirudin Production by Region: 2021 VS 2025 VS 2032 (MT) Table 87. Global Hirudin Production by Region (2021-2026) & (MT) Table 88. Global Hirudin Production Market Share by Region (2021-2026) Table 89. Global Hirudin Production Forecast by Region (2027-2032) & (MT) Table 90. Global Hirudin Production Market Share Forecast by Region (2027-2032) Table 91. Global Hirudin Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 92. Global Hirudin Production Value by Region (2021-2026) & (US$ Million) Table 93. Global Hirudin Production Value Share by Region (2021-2026) Table 94. Global Hirudin Production Value by Region (2027-2032) & (US$ Million) Table 95. Global Hirudin Production Value Share by Region: (2027-2032) & (US$ Million) Table 96. Global Hirudin Market Average Price (USD/Kg) by Region (2021-2026) Table 97. Global Hirudin Market Average Price (USD/Kg) by Region (2027-2032) Table 98. Global Hirudin Consumption by Region: 2021 VS 2025 VS 2032 (MT) Table 99. Global Hirudin Consumption by Region (2021-2026) & (MT) Table 100. Global Hirudin Consumption Market Share by Region (2021-2026) Table 101. Global Hirudin Consumption Forecasted by Region (2027-2032) & (MT) Table 102. Global Hirudin Consumption Forecasted Market Share by Region (2027-2032) Table 103. North America Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 104. North America Hirudin Consumption by Country (2021-2026) & (MT) Table 105. North America Hirudin Consumption by Country (2027-2032) & (MT) Table 106. Europe Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 107. Europe Hirudin Consumption by Country (2021-2026) & (MT) Table 108. Europe Hirudin Consumption by Country (2027-2032) & (MT) Table 109. Asia Pacific Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 110. Asia Pacific Hirudin Consumption by Country (2021-2026) & (MT) Table 111. Asia Pacific Hirudin Consumption by Country (2027-2032) & (MT) Table 112. South America Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 113. South America Hirudin Consumption by Country (2021-2026) & (MT) Table 114. South America Hirudin Consumption by Country (2027-2032) & (MT) Table 115. Middle East & Africa Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 116. Middle East & Africa Hirudin Consumption by Country (2021-2026) & (MT) Table 117. Middle East & Africa Hirudin Consumption by Country (2027-2032) & (MT) Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Hirudin Distributors List Table 121. Hirudin Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Hirudin Product Image Figure 2. Global Hirudin Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hirudin Production Value (2021-2032) & (US$ Million) Figure 4. Global Hirudin Production Capacity (2021-2032) & (MT) Figure 5. Global Hirudin Production (2021-2032) & (MT) Figure 6. Global Hirudin Average Price (USD/Kg) & (2021-2032) Figure 7. Global Top 5 and 10 Hirudin Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Natural Hirudin Image Figure 10. Recombinant Hirudin Image Figure 11. Global Hirudin Production by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Hirudin Production Market Share 2021 VS 2025 VS 2032 Figure 13. Global Hirudin Production Market Share by Type (2021-2032) Figure 14. Global Hirudin Production Value by Type (2021 VS 2025 VS 2032) & (MT) Figure 15. Global Hirudin Production Value Share 2021 VS 2025 VS 2032 Figure 16. Global Hirudin Production Value Share by Type (2021-2032) Figure 17. Thrombosis Disease Image Figure 18. Tumor Disease Image Figure 19. Others Image Figure 20. Global Hirudin Production by Application (2021 VS 2025 VS 2032) & (MT) Figure 21. Global Hirudin Production Market Share 2021 VS 2025 VS 2032 Figure 22. Global Hirudin Production Market Share by Application (2021-2032) Figure 23. Global Hirudin Production Value by Application (2021 VS 2025 VS 2032) & (MT) Figure 24. Global Hirudin Production Value Share 2021 VS 2025 VS 2032 Figure 25. Global Hirudin Production Value Share by Application (2021-2032) Figure 26. Global Hirudin Production by Region: 2021 VS 2025 VS 2032 (MT) Figure 27. Global Hirudin Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Hirudin Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Hirudin Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Hirudin Production Value (2021-2032) & (US$ Million) Figure 31. Europe Hirudin Production Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Hirudin Production Value (2021-2032) & (US$ Million) Figure 33. South America Hirudin Production Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Hirudin Production Value (2021-2032) & (US$ Million) Figure 35. North America Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 36. North America Hirudin Consumption Market Share by Country (2021-2032) Figure 37. U.S. Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 38. Canada Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 39. Mexico Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 40. Europe Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 41. Europe Hirudin Consumption Market Share by Country (2021-2032) Figure 42. Germany Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 43. France Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 44. U.K. Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 45. Italy Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 46. Netherlands Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 47. Asia Pacific Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 48. Asia Pacific Hirudin Consumption Market Share by Country (2021-2032) Figure 49. China Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 50. Japan Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 51. South Korea Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 52. Southeast Asia Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 53. India Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 54. Australia Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 55. South America Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 56. South America Hirudin Consumption Market Share by Country (2021-2032) Figure 57. Brazil Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 58. Argentina Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 59. Chile Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 60. Colombia Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 61. Middle East & Africa Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 62. Middle East & Africa Hirudin Consumption Market Share by Country (2021-2032) Figure 63. Egypt Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 64. South Africa Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 65. Israel Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 66. Türkiye Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 67. GCC Countries Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 68. Hirudin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Hirudin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Hirudin
  • Recombinant Hirudin
Applications
  • Thrombosis Disease
  • Tumor Disease
  • Others
Companies covered
  • The Medicines Company
  • Keyken
  • Minapharm
  • Abbott
  • SALUBRIS
  • Pfizer, Inc
  • Teva Pharmaceutical Industries Ltd
  • DUOPUTAI
  • Pentapharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hirudin Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hirudin Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Hirudin Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Hirudin Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Hirudin Market Dynamics
  1. 2.1 Hirudin Industry Trends
  2. 2.2 Hirudin Industry Drivers
  3. 2.3 Hirudin Industry Opportunities and Challenges
  4. 2.4 Hirudin Industry Restraints
3 Hirudin Market by Manufacturers
  1. 3.1 Global Hirudin Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Hirudin Production by Manufacturers (2021-2026)
  3. 3.3 Global Hirudin Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Hirudin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hirudin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hirudin Manufacturers, Product Type & Application
  7. 3.7 Global Hirudin Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hirudin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hirudin Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Hirudin Tier 1, Tier 2, and Tier 3
4 Hirudin Market by Type
  1. 4.1 Hirudin Type Introduction
  2. 4.1.1 Natural Hirudin
  3. 4.1.2 Recombinant Hirudin
  4. 4.2 Global Hirudin Production by Type
  5. 4.2.1 Global Hirudin Production by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hirudin Production by Type (2021-2032)
  7. 4.2.3 Global Hirudin Production Market Share by Type (2021-2032)
  8. 4.3 Global Hirudin Production Value by Type
  9. 4.3.1 Global Hirudin Production Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hirudin Production Value by Type (2021-2032)
  11. 4.3.3 Global Hirudin Production Value Market Share by Type (2021-2032)
5 Hirudin Market by Application
  1. 5.1 Hirudin Application Introduction
  2. 5.1.1 Thrombosis Disease
  3. 5.1.2 Tumor Disease
  4. 5.1.3 Others
  5. 5.2 Global Hirudin Production by Application
  6. 5.2.1 Global Hirudin Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hirudin Production by Application (2021-2032)
  8. 5.2.3 Global Hirudin Production Market Share by Application (2021-2032)
  9. 5.3 Global Hirudin Production Value by Application
  10. 5.3.1 Global Hirudin Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hirudin Production Value by Application (2021-2032)
  12. 5.3.3 Global Hirudin Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 The Medicines Company
  2. 6.1.1 The Medicines Company Company Information
  3. 6.1.2 The Medicines Company Business Overview
  4. 6.1.3 The Medicines Company Hirudin Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 The Medicines Company Hirudin Product Portfolio
  6. 6.1.5 The Medicines Company Recent Developments
  7. 6.2 Keyken
  8. 6.2.1 Keyken Company Information
  9. 6.2.2 Keyken Business Overview
  10. 6.2.3 Keyken Hirudin Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Keyken Hirudin Product Portfolio
  12. 6.2.5 Keyken Recent Developments
  13. 6.3 Minapharm
  14. 6.3.1 Minapharm Company Information
  15. 6.3.2 Minapharm Business Overview
  16. 6.3.3 Minapharm Hirudin Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Minapharm Hirudin Product Portfolio
  18. 6.3.5 Minapharm Recent Developments
  19. 6.4 Abbott
  20. 6.4.1 Abbott Company Information
  21. 6.4.2 Abbott Business Overview
  22. 6.4.3 Abbott Hirudin Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Abbott Hirudin Product Portfolio
  24. 6.4.5 Abbott Recent Developments
  25. 6.5 SALUBRIS
  26. 6.5.1 SALUBRIS Company Information
  27. 6.5.2 SALUBRIS Business Overview
  28. 6.5.3 SALUBRIS Hirudin Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 SALUBRIS Hirudin Product Portfolio
  30. 6.5.5 SALUBRIS Recent Developments
  31. 6.6 Pfizer, Inc
  32. 6.6.1 Pfizer, Inc Company Information
  33. 6.6.2 Pfizer, Inc Business Overview
  34. 6.6.3 Pfizer, Inc Hirudin Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer, Inc Hirudin Product Portfolio
  36. 6.6.5 Pfizer, Inc Recent Developments
  37. 6.7 Teva Pharmaceutical Industries Ltd
  38. 6.7.1 Teva Pharmaceutical Industries Ltd Company Information
  39. 6.7.2 Teva Pharmaceutical Industries Ltd Business Overview
  40. 6.7.3 Teva Pharmaceutical Industries Ltd Hirudin Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Industries Ltd Hirudin Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
  43. 6.8 DUOPUTAI
  44. 6.8.1 DUOPUTAI Company Information
  45. 6.8.2 DUOPUTAI Business Overview
  46. 6.8.3 DUOPUTAI Hirudin Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 DUOPUTAI Hirudin Product Portfolio
  48. 6.8.5 DUOPUTAI Recent Developments
  49. 6.9 Pentapharm
  50. 6.9.1 Pentapharm Company Information
  51. 6.9.2 Pentapharm Business Overview
  52. 6.9.3 Pentapharm Hirudin Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Pentapharm Hirudin Product Portfolio
  54. 6.9.5 Pentapharm Recent Developments
7 Global Hirudin Production by Region
  1. 7.1 Global Hirudin Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Hirudin Production by Region (2021-2032)
  3. 7.2.1 Global Hirudin Production by Region (2021-2026)
  4. 7.2.2 Global Hirudin Production Forecast by Region (2027-2032)
  5. 7.3 Global Hirudin Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Hirudin Production Value by Region (2021-2032)
  7. 7.4.1 Global Hirudin Production Value by Region (2021-2026)
  8. 7.4.2 Global Hirudin Production Value by Region (2027-2032)
  9. 7.5 Global Hirudin Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Hirudin Production Value (2021-2032)
  12. 7.6.2 Europe Hirudin Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Hirudin Production Value (2021-2032)
  14. 7.6.4 South America Hirudin Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Hirudin Production Value (2021-2032)
8 Global Hirudin Consumption by Region
  1. 8.1 Global Hirudin Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Hirudin Consumption by Region (2021-2032)
  3. 8.2.1 Global Hirudin Consumption by Region (2021-2026)
  4. 8.2.2 Global Hirudin Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Hirudin Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Hirudin Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Hirudin Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Hirudin Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Hirudin Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hirudin Value Chain Analysis
  2. 9.1.1 Hirudin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hirudin Production Mode & Process
  6. 9.2 Hirudin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hirudin Distributors
  9. 9.2.3 Hirudin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst